BFM 89.9

HIGHLIGHTS 
Podcast  >  Bigger Picture  >  Health & Living  >  Why A New TB Vaccine Is An Investment Worth Making

Why A New TB Vaccine Is An Investment Worth Making

Dr Allison Portnoy, Assistant Professor of Global Health, Boston University School of Public Health

29-Mar-24 16:00

Why A New TB Vaccine Is An Investment Worth Making

It’s been more than 100 years since the BCG vaccine was first introduced as a significant tool in our fight against tuberculosis. While the BCG vaccine is still widely rolled out today, it is largely only effective among infants and young children, leaving adolescents and adults still vulnerable to developing TB. Worldwide, TB is one of the deadliest infectious diseases and leaves millions suffering from extended periods of ill-health and disability, especially in low- and middle-income countries. We speak to Dr Allison Portnoy, Assistant Professor of Global Health at the Boston University School of Public Health, to find out what difference a new TB vaccine could make, and how we can convince governments and pharmaceutical companies that this is an investment worth making. 


Image credit: Shutterstock

Produced by: Lim Sue Ann

Presented by: Lim Sue Ann


This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  health policymedical advances

Tags:  the bigger picturehealth and livingglobalhealththreatstuberculosistbvaccinationimmunisationvaccine equityinfectious diseasehealth economics





Play / Pause

Listen now : Talkback Thursday: What is your favourite thing about Sabah and Sarawak?

Today’s Shows



6:00 AM

The 6AM Stretch

Thought-provoking discussions on ideas, people and events shaping our lives.

7:00 AM

World Market Watch

Tony Nash, CEO, Complete Intelligence, tells us where international markets are heading.

7:15 AM

Morning Brief

We recap global and local headlines from today's papers and portals.

7:30 AM

Morning Brief

Dr. Amit Ranjan, Research Fellow at the Institute of South Asian Studies, National University of Singapore, discusses the political situation in the Nepal.

7:45 AM

Morning Brief

Marvin Chen of Bloomberg Intelligence analyzes Asia’s Q2 earnings, which ended on a weak note, 1.8% below expectations.

8:00 AM

The Breakfast Grille

Anthony Pugliese of The Global Institute of Internal Auditors discusses IIA's role and relevance with the adoption of AI.

8:30 AM

Morning Brief

Chris Humphrey, Executive Chairman of the EU-ASEAN Business Council discusses the findings of its annual Business Sentiment Survey.

8:45 AM

Morning Brief

Dato’ Freddie Fernandez of Karyawan discusses how the passing of the Gig Workers’ Bill 2025 would impact gig workers in the creative sector.

9:00 AM

Opening Bell

(REPEAT) Tony Nash, CEO, Complete Intelligence, tells us where international markets are heading.

9:15 AM

Opening Bell

(REPEAT) We take a look at the FBM KLCI as well as regional capital markets.

9:35 AM

Ringgit & Sense

Idham Idris, Director of Corporate Treasury Investment Services at Wealth Vantage Advisory talks about financial goals in your 40s and 50s.

10:05 AM

Open For Business

Dr. Mimi Aminah, Qwork Malaysia

11:00 AM

Tech Talk

John Belizaire, CEO, Soluna Holdings

12:00 PM

Enterprise Explores

Dr Carmelo Ferlito, CEO, Center for Market Education

1:00 PM

The Breakfast Grille Repeat

Anthony Pugliese of The Global Institute of Internal Auditors discusses IIA's role and relevance with the adoption of AI.

2:05 PM

Discovery Hour

3:05 PM

Beyond the Ballot Box

We speak to the co-authors of a new report by the Datum Initiative on the challenges facing women with disabilities in Malaysia.

4:05 PM

Health & Living

We could soon run out of treatments for invasive fungal infections. What will this mean for people with cancer or HIV, who are most vulnerable?

5:00 PM

Top 5 at 5

6:00 PM

Talkback Thursday

What is your favourite thing about Sabah and Sarawak?

8:00 PM

BBC World Service

This episode of Crowd Science looks at milk and the conversations surrounding it.